Matthew Feinstein, MD

Bio

Matthew J. Feinstein, MD, MSc, FACC, FAHA, is the Division Chief of Cardiology and Co-Director of the Cardiovascular Institute at the Indiana University School of Medicine / IU Health. In addition, he is a Professor with Tenure and the Medtronic Zipes Professor of Medicine at Indiana University School of Medicine.

Dr. Feinstein graduated Princeton University with high honors and attended medical school at the Northwestern University School of Medicine, after which he was accepted into the integrated Physician-Scientist training program with internal medicine residency followed by cardiology fellowship at Northwestern. He obtained a Masters Degree in Clinical Investigation during his postdoctoral fellowship.

Clinically, Dr. Feinstein is a general and preventive cardiologist with additional expertise in managing cardiovascular risk in individuals with chronic inflammatory or infectious conditions. Dr. Feinstein also oversees a research program focused on inflammation in heart, vascular, and metabolic disease. This research uses a patient-centered lens to inform discoveries related to dynamic ways inflammation is regulated along the pathway from health to disease.

His research is supported by several federal and society grants on which he serves as PI; he also serves as overall PI and Center Director for one of three Centers funded nationally by the American Heart Association (AHA) Strategically Focused Research Network on Inflammation.

Through these clinical and research efforts, he has led productive collaborations across clinical divisions and departments (including pathology, rheumatology, infectious diseases, pediatrics, vascular surgery, and nephrology), and across the translational research spectrum. He is an active and productive mentor for clinical and research trainees; he has been senior author on manuscripts published by over 20 different trainees over the past 5 years.

Based on these efforts, he has served in several national and scientific leadership roles. He served as Chair of the AHA Prevention Science Committee and a Member of the AHA Committee on Scientific Sessions Planning, as well as an Investigator on the AIDS Clinical Trials Group Inflammation Science Group.

Given expertise in cardiovascular disease in chronic inflammatory and infectious conditions, he served as Writing Chair on a landmark 2019 AHA Scientific Statement on HIV and Cardiovascular Disease, which was published in Circulation and has been cited >500 times.

He regularly serves on NIH study sections covering topics including cardiovascular, metabolic, and inflammation-related disease, as well as methods ranging from preclinical models to clinical and population-based research. He has received an American Society of Clinical Investigation (ASCI) Young Physician-Scientist Award and has contributed invited editorials to journals including JAMA, Circulation Research, JAMA Cardiology, European Heart Journal, and Journal of Infectious Diseases.